ALLO-ASC-SHEET

BIOLOGICAL2 trials

Sponsors

Anterogen Co., Ltd.

Conditions

Diabetic Foot UlcerDystrophic Epidermolysis Bullosa

Phase 2

Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers

Anterogen Co., Ltd.Diabetic Foot Ulcer

Start: 2020-09-08End: 2025-06-30Target: 64Updated: 2023-08-24

Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa

RecruitingNCT05157958

Anterogen Co., Ltd.Dystrophic Epidermolysis Bullosa

Start: 2023-05-01End: 2026-04-28Target: 6Updated: 2024-04-22